Live Markets
Tuesday, July 28, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Healthcare

Cibus, Inc. (CBUS)

NCM · Biotechnology

$1.94+0.13 (+7.18%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$157.1M
P/E (TTM)
EPS
$-1.77
Div Yield
52W Range
$1.09–$4.19
Beta
1.65

Company overview

Next earnings: 2026-08-13(16d)

Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was incorporated in 2010 and is headquartered in San Diego, California.

Peers in Biotechnology

All in industry →

Recent press releases

April 2026

3 months agoDEF 14AHealthcare

Cibus (CBUS) shareholders vote on board, pay, and independent auditor

CBUSCibus, Inc.

# 📢 What This Document Is 🗓️ This document is a Proxy Statement (DEF 14A), which is essentially an official invitation and rulebook for an Annual Meeting of Stockholders. 📑 Its entire purpose is to explain what matters will be voted on, who the directors are, and how stockholders can cast their v

Read summaryView on SEC EDGAR

SEC filings

All filings →
1 recent filing shown in the timeline above. View all SEC filings →

Cibus, Inc. has no reported insider trades in the last 90 days.

Institutional holders

All holders →
As of 2025-12-31 · prior 2025-09-30
FMR LLC$12.7M
7,319,174 sh-0.6%
1,239,364 sh+28.8%
1,143,949 sh0.0%
271,164 sh+46.7%
313,300 sh+9.5%
275,180 sh+4.7%
63,410 sh+1899.7%

People at Cibus, Inc.

All people →

Quarterly financials

Full financials →
Revenue trend
03/25
$869.0K
NI -$46.9M
06/25
$933.0K
NI -$25.4M
09/25
$615.0K
NI -$23.5M
RevenueNI = Net Income
EPS trend (diluted)
Latest: $-0.44
Prior: $-0.61
Revenue sparkline